Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06365125 · ClinicalTrials.gov registry record · NA
College Student Daily Life and Alcohol Use Study
A NA study of Drinking Heavy and Drinking, College, sponsored by Boston University Charles River Campus.
- Active
- Registry status
- NA
- Development phase
- 129
- Enrollment target
- 1
- Study location
NCT06365125: Active NA study of Drinking Heavy and Drinking, College, sponsored by Boston University Charles River Campus.
NCT06365125 is a NA study of Drinking Heavy and Drinking, College that is active but no longer recruiting, run by Boston University Charles River Campus. The registered enrollment target is 129 participants, below the 877-participant average among 3 other Drinking Heavy trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06365125, a NA study of Drinking Heavy and Drinking, College, is active but no longer recruiting, sponsored by Boston University Charles River Campus.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
- 1
- Study location
Study Summary
Heavy alcohol use among college students is associated with a range of negative consequences. However, college students rarely seek resources or treatment to change their alcohol use. Brief alcohol interventions (BAIs) have been developed as an alternative method to address heavy alcohol use among college students and show promise in reducing hazardous alcohol use in college students. Despite the established efficacy of BAIs, effects are often small and short-lived, and additional research is needed to investigate how BAIs can become more efficacious and endure for longer periods of time, particularly for computer-delivered interventions to improve accessibility and scalability of these interventions to a wider range of college students. Boosters or adjunctive components to BAIs have been suggested as a method to enhance the magnitude and duration of intervention effects. However, there remains a need to identify and test booster approaches that are both appealing and engaging to college students and effective in reducing heavy/hazardous alcohol use above and beyond the magnitude and duration seen by BAIs alone. The purpose of the study is to develop and test a novel, text-messaging booster as an adjunct to a current, evidence-based brief intervention, eCHECKUP TO GO, aimed at reducing college student heavy/hazardous alcohol use. Participants will complete baseline measures and will then be randomized to 1 of 3 conditions, stratified by sex at birth: 1) assessment only, 2) BAI only, and 3) Enhanced Intervention (BAI + four weeks of text messaging boosters). It is hypothesized that those randomized to the enhanced intervention condition will show a greater reduction in heavy/hazardous alcohol use at 3-month follow-up compared to the BAI and assessment only groups.
Primary Outcome
Number of past-month heavy drinking episodes (consuming 4+ drinks for females and 5+ drinks for males in one occasion)
Conditions Studied
Interventions
- BEHAVIORAL eCHECKUP TO GO
- BEHAVIORAL Text messaging boosters
Study Locations (1)
Massachusetts
- Boston University Charles River Campus - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2024-03-22 |
| Est. Completion | 2025-05-01 |
| Phase | NA |
What the registry record for NCT06365125 still lists
NCT06365125 is an interventional study that assigns participants to a tested intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap, below the 877-participant average among 3 other Drinking Heavy trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Drinking Heavy appearing as the primary indexed condition, and to 2 interventions - of which eCHECKUP TO GO is the first listed.
NCT06365125 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06365125 about?
NCT06365125 is a clinical study titled "College Student Daily Life and Alcohol Use Study". Heavy alcohol use among college students is associated with a range of negative consequences. However, college students rarely seek resources or treatment to change their alcohol use. Brief alcohol interventions (BAIs) have been developed as an alternative method to address heavy alcohol use among c...
What is the current status of trial NCT06365125?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 129 participants. The study started on 2024-03-22. Estimated completion is 2025-05-01.
What conditions does trial NCT06365125 study?
This clinical trial studies the following conditions: Drinking Heavy, Drinking, College.
What interventions are being tested in trial NCT06365125?
The interventions under investigation include: eCHECKUP TO GO (BEHAVIORAL), Text messaging boosters (BEHAVIORAL).
Who is sponsoring clinical trial NCT06365125?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06365125 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drinking Heavy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI